Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. 1982

G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett

We have studied a man suspected of having primary cortisol resistance on the basis of high 24-h mean plasma cortisol levels (27.4 micrograms/dl) and no stigmata of Cushing's syndrome. His son had slightly elevated 24-h mean plasma cortisol levels (9.9 micrograms/dl; normal 7.52 micrograms/dl). Both had high plasma protein unbound cortisol and increased urinary free cortisol. Plasma ACTH concentration was high, and both were resistant to adrenal suppression by dexamethasone. The father appeared to have mineralocorticoid excess resulting in hypertension, hypokalemia, and metabolic alkalosis. This was found to be due to markedly elevated plasma levels of deoxycorticosterone and corticosterone. The son, who was normotensive, had mildly increased plasma corticosterone and normal deoxycorticosterone levels. To study the apparent end-organ resistance to cortisol, we examined the glucocorticoid receptor in the white cells and fibroblasts of these patients. In both tissues, using both whole cell and cytosol assays, the glucocorticoid receptor was found to have reduced affinity for dexamethasone. In the cytoxol assays, a reduced receptor number was found as well. We conclude that cortisol resistance is a rare familial syndrome owing to an abnormal glucocorticoid receptor with a decreased affinity for cortisol.

UI MeSH Term Description Entries
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D011987 Receptors, Steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Corticosteroid Receptors,Receptors, Corticosteroid,Steroid Receptors,Corticosteroid Receptor,Receptors, Steroids,Steroid Receptor,Receptor, Corticosteroid,Receptor, Steroid,Steroids Receptors
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.

Related Publications

G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
May 1993, The Journal of clinical investigation,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
January 1990, Transactions of the Association of American Physicians,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
February 1989, Journal of steroid biochemistry,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
June 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
January 1995, Steroids,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
January 1991, Problemy endokrinologii,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
November 1986, The Journal of clinical investigation,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
September 2001, Clinical endocrinology,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
January 2016, Molecular & cellular oncology,
G P Chrousos, and A Vingerhoeds, and D Brandon, and C Eil, and M Pugeat, and M DeVroede, and D L Loriaux, and M B Lipsett
January 1986, Advances in experimental medicine and biology,
Copied contents to your clipboard!